Who Owns Lash Group?
Lash Group is owned by Cencora Inc., a publicly traded American pharmaceutical distribution company listed on the NYSE (COR). Cencora operates Lash Group as their patient support services brand, providing comprehensive patient assistance programs and healthcare support services to help patients access medications and treatments.
Parent Company
Cencora Inc.
Founded
1989
Status
Publicly Traded
Headquarters
Conshohocken, Pennsylvania, USA
Who Owns Lash Group?
- Parent Company: Cencora Inc.
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NYSE: COR
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Lash Group | Cencora Inc. | Wholly owned |
History of Lash Group
- Founded: 1989
- Founders: Lash Group founding team
Lash Group was founded in 1989 as a patient support services company dedicated to helping patients access medications and treatments. The company developed expertise in pharmaceutical patient assistance programs, enrollment services, and healthcare support.
Throughout the 1990s and 2000s, Lash Group expanded its service offerings and customer base, becoming a leading provider of patient support services for pharmaceutical companies and healthcare providers. The company developed specialized programs for managing patient enrollment, insurance verification, and medication access.
Lash Group became known for its comprehensive approach to patient support, including assistance with copay reduction programs, patient education, and adherence support. The company's expertise in patient services made it a valuable partner for pharmaceutical manufacturers seeking to improve patient outcomes and medication adherence.
In recent years, Lash Group has focused on expanding its digital capabilities, enhancing patient engagement platforms, and providing integrated support services. The company continues to grow its partnerships with pharmaceutical manufacturers and healthcare providers.
About Cencora Inc.
What does Cencora do?
Cencora distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and internationally. The company also provides manufacturer services, patient support programs, specialty logistics, and veterinary pharmaceutical distribution through its subsidiaries.
Is Cencora publicly traded?
Yes, Cencora, Inc. trades on the New York Stock Exchange under ticker symbol COR. The company has no controlling shareholder, though Walgreens Boots Alliance holds approximately 15% of shares as the largest single investor.
What is Cencora's annual revenue?
In fiscal year 2024 (ended September 30, 2024), Cencora reported revenue of $294.0 billion, a 12.1% increase from the prior fiscal year. The company is one of the largest companies in the United States by revenue.
Why did AmerisourceBergen change its name to Cencora?
AmerisourceBergen changed its name to Cencora in August 2023 to reflect its evolution from a primarily domestic pharmaceutical distributor into a global healthcare solutions organization. The rebranding followed the 2021 acquisition of Alliance Healthcare, which significantly expanded the company's international operations, and was intended to signal the company's broader capabilities beyond traditional drug distribution.
Who is Cencora's CEO?
Robert P. Mauch became President and CEO of Cencora on October 1, 2024, succeeding Steven H. Collis, who had served as CEO since 2011. Collis transitioned to the role of Executive Chairman.
What is Cencora's role in the opioid settlement?
Cencora, along with McKesson and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. Cencora's share of the settlement is approximately $6.1 billion, to be paid over 18 years.
- Founded: 2001
- Headquarters: Conshohocken, Pennsylvania, USA
- Company Type: Publicly Traded
- Stock: NYSE: COR
Where Is Lash Group Made / Based?
- Headquarters: Conshohocken, Pennsylvania, USA
- Manufacturing / Operations: United States
Brands Owned by Cencora Inc.
- AmerisourceBergen - American pharmaceutical distribution brand representing the legacy operations of...
- GoodRx - American healthcare technology platform providing prescription drug price compar...
- MWI Animal Health - Animal health pharmaceutical and supply distributor providing veterinary medicat...
- OneOncology - Physician-led community oncology platform providing practice management, clinica...
- Retina Consultants of America - Leading retina specialist management services organization providing practice ma...
- World Courier - Global specialty logistics and transportation company specializing in time-criti...
- Xcenda - Strategic consulting and market access company providing commercialization suppo...
Lash Group Ownership: Pros & Cons
Advantages
- +Comprehensive patient support and assistance program offerings
- +Integration with Cencora's pharmaceutical distribution network
- +Advanced technology platforms for patient enrollment and engagement
- +Partnerships with major pharmaceutical manufacturers
- +Significant scale enabling efficient patient support services
- +Access to Cencora's healthcare industry expertise and relationships
Considerations
- -Dependency on Cencora's supply chain and corporate policies
- -Complex healthcare regulations affecting patient assistance programs
- -Competition from other patient support service providers
- -Pressure on margins from healthcare cost containment efforts
- -Limited flexibility in certain operational decisions due to corporate structure
- -Regulatory oversight of patient assistance program operations
Frequently Asked Questions About Lash Group
Where to Buy
Disclosure: We may earn commission from purchases
Lash Group on AmazonCompetitors to Lash Group
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cardinal Health | USA | 2010 | Mass Market | North America | All Genders | |
| Piramal Pharma | India | 2007 | Mass Market | Global | Male |
Learn More About Competitors
Cardinal Health Specialty Pharmacy
Owned by Cardinal Health
Specialty pharmaceutical distribution and services provider serving specialty pharmacies, hospitals, and healthcare providers with complex medications owned by Cardinal Health.
Piramal Pharma Solutions
Owned by Piramal Pharma Limited
Global contract development and manufacturing organization providing integrated CDMO services across the drug lifecycle for pharmaceutical companies.
Competitive Analysis
Market Positioning: Lash Group competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Cencora Inc. Stock Information
Jobs at Cencora Inc.
Latest News About Lash Group
Related Articles About Lash Group
View more articles
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
The Truth About 'Made in America' Brand Claims
Many brands market themselves as American-made. But what does that actually mean when the parent company is foreign, the parts come from overseas, and 'assembled in USA' is not the same as 'made in USA'?
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Activase
Prescription thrombolytic medication for treating acute myocardial infarction and stroke, manufactured and marketed by Roche.
Acuvue
American brand of contact lenses and vision care products specializing in daily disposable and extended wear contact lenses, manufactured and marketed by Johnson & Johnson.
Adcetris
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.